Table 1 Clinical characteristics of women included in the study

Age of patients, years

48.7(48.0, 50.0)

53.0 (50.0, 55.0)

 < 0.001

Menopause duration, years

–

3.5 (2.0, 5.0)

–

Hypertension, n (%)

72 (38.1)

117/61.9

0.020

BMI, kg/m²

25.6(24.0, 26.5)

28.6(25.9, 33.2)

 < 0.001

BMI > 25 kg/m², n (%)

87 (51.8%)

170 (78.7%)

 < 0.001

WC, cm

87.0(74.0, 94.0)

94.0(87.0, 108.0)

 < 0.001

WC > 80 cm, n (%)

84 (50%)

191 (88.4%)

 < 0.001

WC/TC

0.81 (0.77, 0.86)

0.86 (0.82, 0.92)

 < 0.001

Metabolic syndrome, n (%)

39/23.2

116/54

 < 0.001

Antihypertensive therapy regimen for women with hypertension:

(n = 72)

(n = 117)

Losartan (100 mg per day), n (%)

68 (94.4%)

39 (33.3%)

 < 0.001

Losartan (100 mg per day) + indapamide (1.5 mg per day), n (%)

4 (5.6%)

64 (54.8%)

 < 0.001

Losartan (100 mg per day) + indapamide (1.5 mg per day) + amlodipine (5 mg per day), n (%)

0 (0%)

14 (11.9%)

0.057